Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Evaluation of 99mTc-sulfonamide and sulfocoumarin derivatives for imaging carbonic anhydrase IX expression.

Nakai M, Pan J, Lin KS, Thompson JR, Nocentini A, Supuran CT, Nakabayashi Y, Storr T.

J Inorg Biochem. 2018 Aug;185:63-70. doi: 10.1016/j.jinorgbio.2018.04.009. Epub 2018 Apr 13.

PMID:
29778927
2.

Melanoma Imaging Using 18F-Labeled α-Melanocyte-Stimulating Hormone Derivatives with Positron Emission Tomography.

Zhang C, Zhang Z, Lin KS, Lau J, Zeisler J, Colpo N, Perrin DM, Bénard F.

Mol Pharm. 2018 Jun 4;15(6):2116-2122. doi: 10.1021/acs.molpharmaceut.7b01113. Epub 2018 May 10.

PMID:
29714486
3.

Preliminary evaluation of 18F-labeled LLP2A-trifluoroborate conjugates as VLA-4 (α4β1 integrin) specific radiotracers for PET imaging of melanoma.

Roxin Á, Zhang C, Huh S, Lepage ML, Zhang Z, Lin KS, Bénard F, Perrin DM.

Nucl Med Biol. 2018 Mar 12;61:11-20. doi: 10.1016/j.nucmedbio.2018.02.005. [Epub ahead of print]

PMID:
29597141
4.

Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with 89Zr for imaging with positron emission tomography.

Rousseau J, Zhang Z, Wang X, Zhang C, Lau J, Rousseau E, Čolović M, Hundal-Jabal N, Bénard F, Lin KS.

Bioorg Med Chem Lett. 2018 Mar 1;28(5):899-905. doi: 10.1016/j.bmcl.2018.01.067. Epub 2018 Feb 2.

PMID:
29426769
5.

89Zr for antibody labeling and in vivo studies - A comparison between liquid and solid target production.

Dias GM, Ramogida CF, Rousseau J, Zacchia NA, Hoehr C, Schaffer P, Lin KS, Bénard F.

Nucl Med Biol. 2018 Mar;58:1-7. doi: 10.1016/j.nucmedbio.2017.11.005. Epub 2017 Nov 16.

PMID:
29291493
6.

Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography.

Nunes PSG, Zhang Z, Kuo HT, Zhang C, Rousseau J, Rousseau E, Lau J, Kwon D, Carvalho I, Bénard F, Lin KS.

J Labelled Comp Radiopharm. 2018 Apr;61(4):370-379. doi: 10.1002/jlcr.3594. Epub 2018 Feb 22.

PMID:
29247455
7.

Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.

Zhang C, Lin KS, Bénard F.

Mol Imaging. 2017 Jan-Dec;16:1536012117737919. doi: 10.1177/1536012117737919.

8.

Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.

Lau J, Lin KS, Bénard F.

Theranostics. 2017 Sep 26;7(17):4322-4339. doi: 10.7150/thno.21848. eCollection 2017. Review.

9.

Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging.

Zhang Z, Lau J, Zhang C, Colpo N, Nocentini A, Supuran CT, Bénard F, Lin KS.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):722-730. doi: 10.1080/14756366.2017.1308928.

PMID:
28385087
10.

Preclinical Melanoma Imaging with 68Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET.

Zhang C, Zhang Z, Lin KS, Pan J, Dude I, Hundal-Jabal N, Colpo N, Bénard F.

Theranostics. 2017 Feb 8;7(4):805-813. doi: 10.7150/thno.17117. eCollection 2017.

11.

Synthesis and evaluation of 18F-labeled CJ-042794 for imaging prostanoid EP4 receptor expression in cancer with positron emission tomography.

Zhang Z, Lau J, Kuo HT, Zhang C, Colpo N, Bénard F, Lin KS.

Bioorg Med Chem Lett. 2017 May 15;27(10):2094-2098. doi: 10.1016/j.bmcl.2017.03.078. Epub 2017 Mar 27.

PMID:
28377057
12.

Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies.

Rousseau J, Zhang Z, Dias GM, Zhang C, Colpo N, Bénard F, Lin KS.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):708-712. doi: 10.1016/j.bmcl.2017.01.052. Epub 2017 Jan 18.

PMID:
28131709
13.

2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion.

Wadsworth BJ, Pan J, Dude I, Colpo N, Bosiljcic M, Lin KS, Benard F, Bennewith KL.

J Nucl Med. 2017 May;58(5):815-820. doi: 10.2967/jnumed.116.183624. Epub 2017 Jan 26.

14.

Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.

Kuo HT, Pan J, Lau J, Zhang C, Zeisler J, Colpo N, Bénard F, Lin KS.

Mol Pharm. 2017 Mar 6;14(3):821-829. doi: 10.1021/acs.molpharmaceut.6b01055. Epub 2017 Feb 2.

PMID:
28094956
15.

Improving the stability of 11C-labeled L-methionine with ascorbate.

Woods M, Leung L, Frantzen K, Garrick JG, Zhang Z, Zhang C, English W, Wilson D, Bénard F, Lin KS.

EJNMMI Radiopharm Chem. 2017;2(1):13. doi: 10.1186/s41181-017-0032-x. Epub 2017 Oct 4.

16.

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography.

Dude I, Zhang Z, Rousseau J, Hundal-Jabal N, Colpo N, Merkens H, Lin KS, Bénard F.

EJNMMI Radiopharm Chem. 2017;2(1):4. doi: 10.1186/s41181-017-0023-y. Epub 2017 Apr 17.

17.

Synthesis and evaluation of a 68Ga-labeled bradykinin B1 receptor agonist for imaging with positron emission tomography.

Amouroux G, Zhang Z, Pan J, Jenni S, Zhang C, Hundal-Jabal N, Colpo N, Zeisler J, Lin KS, Bénard F.

Bioorg Med Chem. 2017 Jan 15;25(2):690-696. doi: 10.1016/j.bmc.2016.11.038. Epub 2016 Nov 23.

PMID:
27908753
18.

Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.

Zhang C, Pan J, Lin KS, Dude I, Lau J, Zeisler J, Merkens H, Jenni S, Guérin B, Bénard F.

Mol Pharm. 2016 Nov 7;13(11):3657-3664. Epub 2016 Oct 3.

PMID:
27669056
19.

One-step synthesis of 4-[(18) F]fluorobenzyltriphenylphosphonium cation for imaging with positron emission tomography.

Zhang Z, Zhang C, Lau J, Colpo N, Bénard F, Lin KS.

J Labelled Comp Radiopharm. 2016 Sep;59(11):467-71. doi: 10.1002/jlcr.3436. Epub 2016 Aug 31.

PMID:
27578168
20.

An imaging agent to detect androgen receptor and its active splice variants in prostate cancer.

Imamura Y, Tien AH, Pan J, Leung JK, Banuelos CA, Jian K, Wang J, Mawji NR, Fernandez JG, Lin KS, Andersen RJ, Sadar MD.

JCI Insight. 2016 Jul 21;1(11). pii: e87850.

Supplemental Content

Loading ...
Support Center